Abstract 4335: JMB2403, a potential best-in-class PD-1-dependent IL2Rβγ-targeting tri-specific antibody for safe and potent immunotherapy
Year: 2026
Type: conference-abstract
Source: Cancer Research
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148796061
Cites:
Cited by:
Related to:
